Centene Corporation
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
Centene scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Centene Corporation increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Centene forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Centene is a member of the Global Alliance for Responsible Media, which aims to demonetize advertisements and suppress content that “vilifies” individuals based on sexual orientation and gender identity, discusses "debated social issues in a negative or partisan context" or spreads "hate speech". For these reasons, Centene receives a High Risk rating.
Board Bias
Expand Summary
CEO of Centene Corporation
Sarah M. London
Summary:
Headquartered in St. Louis, Missouri, Centene Corporation is a member of the Fortune 250 operating in the Health Care Equipment and Services industry. Sarah M. London and Frederick H. Eppinger serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $155,425 to Republican causes and $307,395 to Democratic causes. Under their tenure, Centene Corporation currently holds a 'High Risk' risk rating.
Political Contributions of Leadership:
$155,425
$307,395
Republican
Democrat
Shareholder Proposals
Expand Summary
Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
---|---|---|---|---|---|
5/14/24 | Environmental | John Chevedden | Managing Climate Risk Through Science-Based Targets and Transition Planning | Against | N/A |
5/10/23 | Social | New York State Common Retirement Fund | Report on Maternal Health Benefits | Against | 12.40% |
5/10/23 | Governance | John Chevedden | Require Shareholder Approval of Termination Pay | Against | 9.20% |
4/26/22 | Governance | John Chevedden | Provide Right to Call Special Meetings - Ownership Req. at 10% | Against | 55.22% |